81255

Gene analysis (hexosaminidase a) common variants

Medicare pricing data for 37 providers across 8 states

🤖AI Overview

Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.

💡 What You Should Know

Gene analysis (hexosaminidase a) common variants (HCPCS code 81255) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $50.42, but hospitals typically charge $58.61 — a 1.2x markup. Prices vary significantly by state and provider.

🏷️ Typical Out-of-Pocket Cost

$10.08

Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $50.42, your out-of-pocket cost would be approximately $10.08. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.

Average Allowed Cost
$50.42
Average Hospital Charge
$58.61
Markup Ratio
1.2x

What Hospitals Charge vs. What Medicare Pays

Hospital Charge$58.61
Medicare Allowed$50.42
Medicare Payment$50.42

Hospitals charge 1.2x more than what Medicare allows for this procedure. Medicare actually pays $50.42 on average.

Cost by State

Medicare-allowed amounts vary significantly by state

StateAllowed CostHospital ChargeProvidersServicesvs. National
Florida$50$69105960.0%
Louisiana$50$602630.0%
Oklahoma$50$8232450.0%
Pennsylvania$50$5211,1070.0%
Texas$50$55136,1920.0%
Arizona$50$751600.0%
Colorado$50$2402140.0%
New Jersey$50$6352,973-0.0%

⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.

Related from TheDataProject.ai

💊 Need post-procedure medications? Check costs on OpenPrescriber